Characterization of kinetics and products of the Baeyer-Villiger oxygenase MtmOIV, the key enzyme of the biosynthetic pathway toward the natural product anticancer drug mithramycin from Streptomyces argillaceus

J Am Chem Soc. 2005 Dec 21;127(50):17594-5. doi: 10.1021/ja055750t.

Abstract

MtmOIV, the key oxygenase of the mithramycin biosynthetic pathway in Streptomyces argillaceus, was proven to act initially as Baeyer-Villiger monooxygenase, but may also catalyze various follow-up reaction steps. The reaction of the overexpressed pure His6-tagged enzyme with its substrate premithramycin B was studied. Various intermediates and products were isolated and physicochemically characterized, several of them being previously unknown compounds. This is the first example in which a bacterial enzyme was unequivocally proven to act as Baeyer-Villigerase with its natural substrate, that is, in its natural context.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Escherichia coli / enzymology
  • Escherichia coli / genetics
  • Flavin-Adenine Dinucleotide / metabolism
  • Kinetics
  • NADP / metabolism
  • Oxidation-Reduction
  • Oxygenases / biosynthesis
  • Oxygenases / genetics
  • Oxygenases / metabolism*
  • Plicamycin / biosynthesis*
  • Streptomyces / enzymology
  • Streptomyces / genetics
  • Streptomyces / metabolism*

Substances

  • Flavin-Adenine Dinucleotide
  • NADP
  • Oxygenases
  • Plicamycin